 |
Adenoviral vector-RheoSwitch Therapeutic System-human interleukin 12 + veledimex |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2015-07-23 00:00:00 |
| Sponsor | Ziopharm Oncology, Inc.;One First Avenue, Navy Yard Plaza;Boston, Massachusetts, 02129 |
Related Access Program